1.
Zadro Y, Lafaurie M, Sommet A, Lapeyre-Mestre M, Moulis G. No increased risk of acute myeloid leukemia in adults with primary immune thrombocytopenia treated with thrombopoietin receptor agonists: a French nationwide population-based study. haematol [Internet]. 2026Aug.1 [cited 2026Aug.10];111(8):2824-7. Available from: https://haematologica.org/article/view/13388